Peer-reviewedLicence not statedJournal of controlled release : official journal of the Controlled Release Society
Strategic engineering B cell immunity for cancer immunotherapy
- 1Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seatle, WA, USA.
Related
- Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II
- 944 Succinate-based metabolic reprogramming of innate and adaptive immunity for ovarian cancer immunotherapy
- Post-Translational Control of PD-L1 in Cancer Immunity and Immunotherapy Resistance
- Innate immunity-stroma crosstalk in pancreatic cancer: overcoming spatial and metabolic barriers to immunotherapy
- CAR-NK cell immunotherapy: a comprehensive review of engineering platforms, clinical applications in hematological and solid tumors.
BibTeX
@article{li2026strategic,
title = {{Strategic engineering B cell immunity for cancer immunotherapy}},
author = {Chengyi Li and Hrishi Venkatesh and Lam Trieu and Lawrence Fong},
journal = {Journal of controlled release : official journal of the Controlled Release Society},
year = {2026},
month = jul,
doi = {10.1016/j.jconrel.2026.115182},
url = {https://doi.org/10.1016/j.jconrel.2026.115182},
}
RIS
TY - JOUR
TI - Strategic engineering B cell immunity for cancer immunotherapy
AU - Chengyi Li
AU - Hrishi Venkatesh
AU - Lam Trieu
AU - Lawrence Fong
PY - 2026
DA - 2026/07/15
JO - Journal of controlled release : official journal of the Controlled Release Society
DO - 10.1016/j.jconrel.2026.115182
UR - https://doi.org/10.1016/j.jconrel.2026.115182
SN - 0168-3659
SN - 1873-4995
ER -